Skip to content

Pulsed Ultrasound to Speed-up Healing after Intramedullary nailing of Tibia fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN90844675
Enrollment
250
Registered
2008-09-18
Start date
2008-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closed or I° open fractures of the tibia Injury, Occupational Diseases, Poisoning Fracture of lower leg, including ankle

Interventions

Experimental: pulsed, low-energetic ultrasound (Exogen, Smith & Nephew), applied daily for three months Control: standard of care The total duration of follow-up is one year after randomisation.

Sponsors

German Employer's Liability Insurance for the Administrative Professions (Verwaltungs-Berufsgenossenschaft [VBG]) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women 2. Greater than 18 years old 3. With closed or I° open fractures of the tibia that had been treated by reamed or unreamed locking intramedullary nails less than 10 days prior to randomisation. Patients with fractures of the lateral malleolus, fixed by plates, as well as patients with minor concomitant injuries (bruises, sprains) will be offered trial participation.

Exclusion criteria

Exclusion criteria: 1. Multiple injuries/polytrauma 2. Greater than I° open fractures 3. Pregnant or breastfeeding women 4. Pathological fractures

Design outcomes

Primary

MeasureTime frame
Bony union three months (+/- 1 week) after randomisation, as assessed on plain radiographs by independent, blinded raters.

Secondary

MeasureTime frame
1. Delayed union and non-union rates 2. Health-related quality of life (36-item Short Form Health Survey [SF-36], EuroQoL instrument [EQ-5D]) 3. Functional outcomes (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]) 4. Duration of sick leave 5. Cost-utility 6. Serious adverse events (SAE) Secondary outcomes will be assessed after 6 weeks, 3, 6, and 12 months.

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026